Sexually transmitted infections, including HIV, in the Netherlands in 2013

Het aantal mensen dat zich bij een Centrum Seksuele Gezondheid heeft laten testen op een seksueel overdraagbare aandoening (soa) is verder gestegen in 2013. Het percentage mensen met een soa is voor het eerst licht gedaald (met 0,4 procent) sinds 2007. Desondanks blijft dit percentage hoog (14,7 procent). Een goed functionerende soa-monitoring blijft daarom essentieel om zicht te houden op relevante trends, opkomende soa binnen groepen die een grotere kans hebben er een op te lopen, en de effectiviteit van preventieprogramma's. De Centra Seksuele Gezondheid (CSG), voorheen soa-poli's, bieden hoogrisicogroepen de mogelijkheid om zich gratis te laten testen op soa en verstrekken medicatie als er een wordt vastgesteld. Het totaal aantal consulten in 2013 bedroeg 133.585 en is met 10 procent toegenomen ten opzichte van 2012. Van alle bezoekers werden de meeste soa gediagnosticeerd bij mensen die ervoor gewaarschuwd waren dat ze mogelijk een soa hadden opgelopen, mensen jonger dan 25 jaar, migranten uit gebieden waar soa en hiv veel voorkomen (bijvoorbeeld Afrika, Zuid-Amerika of Oost-Europa), of mannen die seks hebben met mannen (MSM). Chlamydia Net als in voorgaande jaren was chlamydia de meest gediagnosticeerde soa bij de CSG in 2013 (15.767 diagnoses). Het percentage mensen dat chlamydia had, daalde licht ten opzichte van 2012 (van 12,2 naar 11,8 procent). Chlamydia werd het meest vastgesteld bij heteroseksuelen, zowel mannen als vrouwen, onder de 25 jaar. Na de uitschieter in 2012 van het aantal en percentage mensen met een agressieve variant van chlamydia, lymphogranuloma venereum, zijn deze cijfers weer afgenomen naar het niveau van de jaren daarvoor (7 procent in 2013). Gonorroe Het percentage personen met een gonorroe-infectie bij de CSG bleef in 2013 stabiel ten opzichte van 2012 (3,6 procent in 2012 en 3,4 procent in 2013), nadat het in de voorgaande jaren licht was gestegen. Deze soa werd het meest gediagnosticeerd bij MSM. Het blijft belangrijk om te volgen of de gonorroe-bacterie resistent raakt tegen de antibiotica die in Nederland voorgeschreven worden, de zogenoemde derde generatie cefalosporines. In diverse Europese landen is deze resistentie waargenomen. Hiv Het aantal personen met een hiv-infectie, gediagnosticeerd bij een van de CSG, is in 2013 gelijk gebleven ten opzichte van 2012 (358 versus 356 in 2012). Het percentage positieve testen daalt sinds 2008: van 3,0 procent naar 1,4 procent bij MSM in 2013. Het percentage mensen dat in een laat stadium van een hiv-infectie bij een hiv-behandelcentrum komt, is de afgelopen jaren gedaald. Het is van belang om tijdig de hiv-diagnose te stellen en zo snel mogelijk de behandeling te starten, omdat hierdoor de gezondheidsschade bij de patiënt verkleind kan worden. Ook neemt door behandeling de besmettelijkheid af, waardoor de kans kleiner is dat hiv wordt overgedragen.In 2013, more people were tested for sexually transmitted infections (STI) at Dutch STI clinics than in previous years. Although the percentage of people with an STI showed a slight decrease (0.4 per cent) for the first time since 2007, it remained high at 14.7 per cent. Effective STI monitoring remains essential for the identification of relevant trends, emerging STIs in high-risk groups, and the effectiveness of prevention programmes. STI clinics offer high-risk groups access to free testing for STI and provide care and treatment if an STI is diagnosed. The total number of consultations in 2013 was 133,585, an increase of 10% compared with 2012. In 2013, STI clinic attendees with an STI were mainly people who reported having been notified of their possible exposure to STI, people aged 20-24, people originating from areas in which STI/HIV is common (e.g. Africa, South America or Eastern Europe), and men who have sex with men (MSM). Chlamydia With 15,767 cases, chlamydia remains the most commonly diagnosed STI in 2013. The percentage of people diagnosed with chlamydia was slightly lower in 2013 than in 2012 (11.8 versus 12.2 respectively). Chlamydia was primarily diagnosed in heterosexuals younger than 25 years old and in both men and women. Following the increase in the number and percentage of lymphogranuloma venereum (LGV; an aggressive variant of chlamydia) infections in 2012, these numbers declined to a level comparable to previous years in 2013. Gonorrhoea Whereas the percentage of people with a gonorrhoea infection slightly had increased in previous years, the percentage remained stable in 2013 (3.4 per cent) compared with 2012 (3.6 per cent). Gonorrhoea was mostly diagnosed in MSM. It remains important to monitor the resistance of the gonorrhoea bacteria against the antibiotic currently recommended in the Netherlands, a third-generation cephalosporin. A rising rate of resistance to this antibiotic has been observed in several European countries. HIVThe number of people diagnosed with HIV at STI clinics in 2013 was similar to that of 2012 (358 versus 356 respectively). Among MSM, the percentage of positive HIV tests decreased from 3.0 per cent in 2008 to 1.4 per cent in 2013. The percentage of HIV-positive people who were diagnosed at a late stage of the infection has decreased in previous years. Early diagnosis and treatment of an HIV infection is important because of individual health benefits and the potential reduction of HIV transmission

‘Test n Treat (TnT)’: a cluster-randomised feasibility trial of frequent, rapid-testing and same-day, on-site treatment to reduce rates of chlamydia in high-risk further education college students: statistical analysis plan

Background There are high rates of sexually transmitted infections (STIs) in ethnically diverse, sexually active students aged 16–24 years attending London further education (FE) colleges. However, uptake of chlamydia screening remains low. The TnT study aims to assess the feasibility of conducting a future trial in FE colleges to investigate if frequent, rapid, on-site testing and treatment (TnT) reduces chlamydia rates. This article presents the statistical analysis plan for the main study publication as approved and signed off by the Trial Management Group prior to the first data extraction for the final report. Methods/design TnT is a cluster-randomised feasibility trial conducted over 7 months with parallel qualitative and economic assessments. Colleges will be randomly allocated into the intervention (TnT) or the control group (no TnT). Six FE colleges in London will be included. At each college for 2 days, 80 consecutive sexually active students aged 16–24 years (total 480 students across all six colleges) will be recruited from public areas and asked to provide baseline samples. One and 4 months after recruitment intervention colleges will be visited on two consecutive days by the TnT team where participating students will be texted and invited to come for same-day, on-site, rapid chlamydia testing and, if positive, treatment. Participants in the control colleges will receive ‘thank you’ texts 1 and 4 months after recruitment. Seven months after recruitment, participants from both groups will be invited to complete questionnaires and provide samples for TnT. All samples will be tested, and same-day treatment offered to participants with positive results. Key feasibility outcomes include: recruitment rates, testing and treatment uptake rates (at 1 and 4 months) and follow-up rates (at 7 months). Trial registration ISRCTN 58038795. Registered on 31 August 2016

The impact of low erythrocyte density in human blood on the fitness and energetic reserves of the African malaria vector Anopheles gambiae

Background Anaemia is a common health problem in the developing world. This condition is characterized by a reduction in erythrocyte density, primarily from malnutrition and/or infectious diseases such as malaria. As red blood cells are the primary source of protein for haematophagous mosquitoes, any reduction could impede the ability of mosquito vectors to transmit malaria by influencing their fitness or that of the parasites they transmit. The aim of this study was to determine the impact of differences in the density of red blood cells in human blood on malaria vector (Anopheles gambiae sensu stricto) fitness. The hypotheses tested are that mosquito vector energetic reserves and fitness are negatively influenced by reductions in the red cell density of host human blood meals commensurate with those expected from severe anaemia. Methods Mosquitoes (An. gambiae s.s.) were offered blood meals of different packed cell volume(PCV) of human blood consistent with those arising from severe anaemia (15%) and normalPCV (50%). Associations between mosquito energetic reserves (lipid, glucose and glycogen)and fitness measures (reproduction and survival) and blood meal PCV were investigated. Results The amount of protein that malaria vectors acquired from blood feeding (indexed by haematin excretion) was significantly reduced at low blood PCV. However, mosquitoes feeding on blood of low PCV had the same oviposition rates as those feeding on blood of normal PCV, and showed an increase in egg production of around 15%. The long-term survival of An. gambiae s.s was reduced after feeding on low PCV blood, but PCV had no significant impact on the proportion of mosquitoes surviving through the minimal period required to develop and transmit malaria parasites (estimated as 14 days post-blood feeding). The impact of blood PCV on the energetic reserves of mosquitoes was relatively minor. Conclusions These results suggest that feeding on human hosts whose PCV has been depleted due to severe anaemia does not significantly reduce the fitness or transmission potential of malaria vectors, and indicates that mosquitoes may be able exploit resources for reproduction more efficiently from blood of low rather than normal PCV

Measuring hospital-wide activity volume for patient safety and infection control: a multi-centre study in Japan

<p>Abstract</p> <p>Background</p> <p>In Japan, as in many other countries, several quality and safety assurance measures have been implemented since the 1990's. This has occurred in spite of cost containment efforts. Although government and hospital decision-makers demand comprehensive analysis of these activities at the hospital-wide level, there have been few studies that actually quantify them. Therefore, the aims of this study were to measure hospital-wide activities for patient safety and infection control through a systematic framework, and to identify the incremental volume of these activities implemented over the last five years.</p> <p>Methods</p> <p>Using the conceptual framework of incremental activity corresponding to incremental cost, we defined the scope of patient safety and infection control activities. We then drafted a questionnaire to analyze these realms. After implementing the questionnaire, we conducted several in-person interviews with managers and other staff in charge of patient safety and infection control in seven acute care teaching hospitals in Japan.</p> <p>Results</p> <p>At most hospitals, nurses and clerical employees acted as the main figures in patient safety practices. The annual amount of activity ranged from 14,557 to 72,996 person-hours (per 100 beds: 6,240; per 100 staff: 3,323) across participant hospitals. Pharmacists performed more incremental activities than their proportional share. With respect to infection control activities, the annual volume ranged from 3,015 to 12,196 person-hours (per 100 beds: 1,141; per 100 staff: 613). For infection control, medical doctors and nurses tended to perform somewhat more of the duties relative to their share.</p> <p>Conclusion</p> <p>We developed a systematic framework to quantify hospital-wide activities for patient safety and infection control. We also assessed the incremental volume of these activities in Japanese hospitals under the reimbursement containment policy. Government and hospital decision makers can benefit from this type of analytic framework and its empirical findings.</p

Bologna guidelines for diagnosis and management of adhesive small bowel obstruction (ASBO) : 2017 update of the evidence-based guidelines from the world society of emergency surgery ASBO working group

Background: Adhesive small bowel obstruction (ASBO) is a common surgical emergency, causing high morbidity and even some mortality. The adhesions causing such bowel obstructions are typically the footprints of previous abdominal surgical procedures. The present paper presents a revised version of the Bologna guidelines to evidence-based diagnosis and treatment of ASBO. The working group has added paragraphs on prevention of ASBO and special patient groups. Methods: The guideline was written under the auspices of the World Society of Emergency Surgery by the ASBO working group. A systematic literature search was performed prior to the update of the guidelines to identify relevant new papers on epidemiology, diagnosis, and treatment of ASBO. Literature was critically appraised according to an evidence-based guideline development method. Final recommendations were approved by the workgroup, taking into account the level of evidence of the conclusion. Recommendations: Adhesion formation might be reduced by minimally invasive surgical techniques and the use of adhesion barriers. Non-operative treatment is effective in most patients with ASBO. Contraindications for non-operative treatment include peritonitis, strangulation, and ischemia. When the adhesive etiology of obstruction is unsure, or when contraindications for non-operative management might be present, CT is the diagnostic technique of choice. The principles of non-operative treatment are nil per os, naso-gastric, or long-tube decompression, and intravenous supplementation with fluids and electrolytes. When operative treatment is required, a laparoscopic approach may be beneficial for selected cases of simple ASBO. Younger patients have a higher lifetime risk for recurrent ASBO and might therefore benefit from application of adhesion barriers as both primary and secondary prevention. Discussion: This guideline presents recommendations that can be used by surgeons who treat patients with ASBO. Scientific evidence for some aspects of ASBO management is scarce, in particular aspects relating to special patient groups. Results of a randomized trial of laparoscopic versus open surgery for ASBO are awaited.Peer reviewe

Demographic and spatial predictors of anemia in women of reproductive age in Timor-Leste: Implications for health program prioritization

10.1371/journal.pone.0091252PLoS ONE93-POLN

Budesonide/formoterol as effective as prednisolone plus formoterol in acute exacerbations of COPD A double-blind, randomised, non-inferiority, parallel-group, multicentre study

<p>Abstract</p> <p>Background</p> <p>Oral corticosteroids and inhaled bronchodilators with or without antibiotics represent standard treatment of COPD exacerbations of moderate severity. Frequent courses of oral steroids may be a safety issue. We wanted to evaluate in an out-patient setting whether a 2-week course of inhaled budesonide/formoterol would be equally effective for treatment of acute COPD exacerbations as standard therapy in patients judged by the investigator not to require hospitalisation.</p> <p>Methods</p> <p>This was a double-blind, randomised, non-inferiority, parallel-group, multicentre study comparing two treatment strategies; two weeks' treatment with inhaled budesonide/formoterol (320/9 μg, qid) was compared with prednisolone (30 mg once daily) plus inhaled formoterol (9 μg bid) in patients with acute exacerbations of COPD attending a primary health care centre. Inclusion criteria were progressive dyspnoea for less than one week, FEV₁30–60% of predicted normal after acute treatment with a single dose of oral corticosteroid plus nebulised salbutamol/ipratropium bromide and no requirement for subsequent immediate hospitalisation, i.e the clinical status after the acute treatment allowed for sending the patient home.</p> <p>A total of 109 patients (mean age 67 years, 33 pack-years, mean FEV₁45% of predicted) were randomized to two weeks' double-blind treatment with budesonide/formoterol or prednisolone plus formoterol and subsequent open-label budesonide/formoterol (320/9 μg bid) for another 12 weeks. Change in FEV₁was the primary efficacy variable. Non-inferiority was predefined.</p> <p>Results</p> <p>Non-inferiority of budesonide/formoterol was proven because the lower limit of FEV₁-change (97.5% CI) was above 90% of the efficacy of the alternative treatment. Symptoms, quality of life, treatment failures, need for reliever medication (and exacerbations during follow-up) did not differ between the groups. No safety concerns were identified.</p> <p>Conclusion</p> <p>High dose budesonide/formoterol was as effective as prednisolone plus formoterol for the ambulatory treatment of acute exacerbations in non-hospitalized COPD patients. An early increase in budesonide/formoterol dose may therefore be tried before oral corticosteroids are used.</p> <p>Clinical trial registration</p> <p>NCT00259779</p

Seksueel overdraagbare aandoeningen, waaronder hiv, in Nederland in 2016

In 2016, the number of people who were tested at a Dutch STI clinic for a sexually transmitted infection (STI) increased, after a decrease in 2015. The percentage of people diagnosed with an STI has also increased, to 18.4 percent in 2016. It is estimated that the number of STI consultations at the general practitioner has decreased slightly. Chlamydia remains the most common STI in heterosexuals. Gonorrhoea is more common than chlamydia in men who have sex with men (MSM). STI clinics offer high-risk groups the opportunity for free STI testing. In 2016, a total of 143,139 consultations were registered at the STI clinics, an increase of 5 percent compared to 2015. The percentage of detected STIs varied per municipal health centre (GGD), ranging from 12.8 to 20.9 percent. Most STIs were detected in people infected with HIV, followed by people who had been notified for an STI. Chlamydia In 2016, 14.5 percent of STI clinic attendees were infected with chlamydia (20,698 diagnoses; an increase of 11 percent compared to the previous year). This increase can be explained in part because, since 2015, STI clinics more strictly prioritise people with a high risk of STI. The biggest increase was seen in heterosexual men (from 16.1 in 2015 to 18.0 percent in 2016). In women, the percentage of chlamydia diagnoses increased from 14.2 to 15.4. In MSM, the percentage has been stable around 10 percent for years. Gonorrhoea The number of gonorrhoea diagnoses at the STI clinics has risen in the past year with 13 percent, to 6,092 infections. The percentage of positive tests in heterosexual men (1.7 percent) and women (1.4 percent) remained stable, compared to previous years. In MSM, the percentage has increased from 10.7 percent in 2015 to 11.3 percent in 2016. The STI clinics have not yet found cases of gonorrhoea resistant to the first option antibiotic, Ceftriaxone. The number of gonorrhoea infections diagnosed by general practitioners in 2015 saw a slight decline among women, but an increase among men of 20 percent compared to 2014. Syphilis In 2016, the number of syphilis diagnoses increased by 30 percent compared to 2015, totalling 1,223 infections. This increase is mainly caused by an increase in the number of diagnoses in MSM, both those with and without HIV. Out of all syphilis infections, 95 percent was diagnosed in MSM. The percentage of positive diagnoses in heterosexual men and women remains very low; 0.19 and 0.07 percent of all consultations that tested for syphilis, respectively. HIV In 2016, 285 new HIV diagnoses were detected at the STI clinics, approximately the same number as in 2015 (288); 93 percent was detected in MSM. The percentage of HIV diagnoses in MSM decreased, from 2.8 percent in 2007 to 0.8 percent in 2016. The number of HIV patients that had their 'first care' encounter at a Dutch HIV treatment centre decreased again, from 1,033 cases in 2015 to 976 in 2016. Out of these people, 666 received their diagnosis in 2016Het aantal mensen dat zich bij een Centrum Seksuele Gezondheid (CSG) heeft laten testen op een seksueel overdraagbare aandoening (soa) is, na een daling in 2015, in 2016 weer toegenomen. Het percentage bij wie een soa werd vastgesteld is ook gestegen, tot 18,4 procent in 2016. Naar schatting is het aantal soa-consulten bij huisartsen licht gedaald. Chlamydia blijft de meest voorkomende soa onder heteroseksuelen. Onder mannen die seks hebben met mannen (MSM) werd vaker gonorroe dan chlamydia gevonden. De CSG's bieden hoog-risicogroepen de mogelijkheid om zich gratis te laten testen op soa's. In totaal zijn er in 2016 143.139 consulten geregistreerd bij de CSG's, een stijging van 5 procent ten opzichte van 2015. Het percentage gevonden soa's varieerde tussen de GGD-en; van 12,8 tot 20,9. De meeste soa's zijn gevonden bij mensen met hiv, gevolgd door mensen die waren gewaarschuwd voor een soa. Chlamydia In 2016 had 14,5 procent van de CSG-bezoekers een chlamydia-infectie (20.698 diagnoses; een toename van 11 procent ten opzichte van het jaar ervoor). Deze stijging is mogelijk deels te verklaren doordat GGD-en sinds 2015 eerder voorrang verlenen aan personen met hoog risico op soa. De grootste toename was te zien bij heteroseksuele mannen (van 16,1 in 2015 naar 18,0 procent in 2016). Bij vrouwen nam het percentage vastgestelde chlamydia toe van 14,2 naar 15,4. Onder MSM ligt dit percentage al jaren rond 10 procent. Gonorroe Het aantal gonorroe-diagnoses bij de CSG is het afgelopen jaar met 13 procent toegenomen tot 6.092 infecties. Het percentage positieven onder heteroseksuele mannen (1,7 procent) en vrouwen (1,4 procent) bleef stabiel ten opzichte van voorgaande jaren. Onder MSM is het percentage toegenomen van 10,7 procent in 2015 naar 11,3 procent in 2016. Bij CSG-bezoekers is nog steeds geen gonorroe resistent gevonden tegen het 'eerstekeus' antibioticum ceftriaxon. Het aantal gonorroe-infecties gediagnosticeerd door huisartsen in 2015 nam licht af onder vrouwen, maar steeg onder mannen met 20 procent ten opzichte van 2014. Syfilis In 2016 is het aantal diagnoses van syfilis met 30 procent gestegen ten opzichte van 2015, tot 1.223 infecties. Deze stijging komt voornamelijk door een toename in het aantal diagnoses onder MSM, zowel met als zonder hiv. Van alle syfilis-infecties werd 95 procent bij MSM vastgesteld. Het percentage positieve diagnoses onder heteroseksuele mannen en vrouwen blijft zeer laag; respectievelijk 0,19 en 0,07 procent van alle consulten waarin getest werd op syfilis. Hiv In 2016 zijn 285 nieuwe diagnoses van hiv gesteld bij de CSG, vrijwel evenveel als in 2015 (288). Drieënnegentig procent daarvan werd bij MSM vastgesteld. Het percentage hiv-diagnoses bij MSM is gedaald van 2,8 procent in 2007 tot 0,8 procent in 2016. Het aantal hiv-patiënten dat voor het eerst 'in zorg' was bij de Nederlandse hiv-behandelcentra daalde opnieuw, van 1.033 gevallen in 2015 tot 976 in 2016. Van hen hadden 666 personen de diagnose in 2016 gekregenMinisterie van VW

Narrow-band imaging does not improve detection of colorectal polyps when compared to conventional colonoscopy: a randomized controlled trial and meta-analysis of published studies

<p>Abstract</p> <p>Background</p> <p>A colonoscopy may frequently miss polyps and cancers. A number of techniques have emerged to improve visualization and to reduce the rate of adenoma miss.</p> <p>Methods</p> <p>We conducted a randomized controlled trial (RCT) in two clinics of the Gastrointestinal Department of the Sanitas University Foundation in Bogota, Colombia. Eligible adult patients presenting for screening or diagnostic elective colonoscopy were randomlsy allocated to undergo conventional colonoscopy or narrow-band imaging (NBI) during instrument withdrawal by three experienced endoscopists. For the systematic review, studies were identified from the Cochrane Library, PUBMED and LILACS and assessed using the Cochrane risk of bias tool.</p> <p>Results</p> <p>We enrolled a total of 482 patients (62.5% female), with a mean age of 58.33 years (SD 12.91); 241 into the intervention (NBI) colonoscopy and 241 into the conventional colonoscopy group. Most patients presented for diagnostic colonoscopy (75.3%). The overall rate of polyp detection was significantly higher in the conventional group compared to the NBI group (RR 0.75, 95%CI 0.60 to 0.96). However, no significant differences were found in the mean number of polyps (MD -0.1; 95%CI -0.25 to 0.05), and the mean number of adenomas (MD 0.04 95%CI -0.09 to 0.17). Meta-analysis of studies (regardless of indication) did not find any significant differences in the mean number of polyps (5 RCT, 2479 participants; WMD -0.07 95% CI -0.21 to 0.07; I2 68%), the mean number of adenomas (8 RCT, 3517 participants; WMD -0.08 95% CI -0.17; 0.01 to I2 62%) and the rate of patients with at least one adenoma (8 RCT, 3512 participants, RR 0.96 95% CI 0.88 to 1,04;I2 0%).</p> <p>Conclusion</p> <p>NBI does not improve detection of colorectal polyps when compared to conventional colonoscopy (Australian New Zealand Clinical Trials Registry <a href="http://www.anzctr.org.au/ACTRN12610000456055.aspx">ACTRN12610000456055</a>).</p